Guangzhou Darui Biotechnology Co., Ltd. announced that it expects to receive CNY 219.999978 million in funding from Daan Gene Co., Ltd., Guangzhou Guochuang Equity Investment Partnership (Limited Partnership)
June 29, 2021
Share
Guangzhou Darui Biotechnology Co., Ltd. announced a private placement of 15,907,446 shares at an issue price of CNY 13.83 per share for gross proceeds of CNY 219,999,978.18 on June 30, 2021. The transaction will include participation from returning investor Daan Gene Co., Ltd. for 15,184,381 shares and will hold 49.6901% stake and from new investor Guangzhou Guochuang Equity Investment Partnership (Limited Partnership) for 723,065 shares for 0.3106% stake in the company. The transaction has been approved by Daan Gene Co., Ltd. in seventh board of directors at the sixth interim meeting of 2021 and the seventh board of supervisors at the fifth interim meeting of 2021 and needs approval of fifth extraordinary general meeting of shareholders in 2021.
Da An Gene Co., Ltd. specializes in the development, manufacture and marketing of molecular diagnosis products for infectious and epidemic diseases. The group offers real-time polymerase chain reaction instruments (QPCR), immunological products, screening systems for cervical cancer, sequencing tools, blood collection tubes and food safety products.
Guangzhou Darui Biotechnology Co., Ltd. announced that it expects to receive CNY 219.999978 million in funding from Daan Gene Co., Ltd., Guangzhou Guochuang Equity Investment Partnership (Limited Partnership)